Chi Dae Kim

927 total citations
28 papers, 809 citations indexed

About

Chi Dae Kim is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Chi Dae Kim has authored 28 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Physiology and 6 papers in Neurology. Recurrent topics in Chi Dae Kim's work include Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Chi Dae Kim is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Chi Dae Kim collaborates with scholars based in South Korea, United States and Ethiopia. Chi Dae Kim's co-authors include Ki Whan Hong, So Youn Park, Won Suk Lee, Hwa Kyoung Shin, Jeong Hyun Lee, Byung Yong Rhim, Yung Woo Shin, Seung Jin Lee, Sun Sik Bae and Raj K. Goyal and has published in prestigious journals such as PLoS ONE, Brain Research and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Chi Dae Kim

28 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Dae Kim South Korea 17 303 224 116 101 101 28 809
Hui Fu China 21 497 1.6× 185 0.8× 88 0.8× 69 0.7× 106 1.0× 52 1.2k
Masahiro Okouchi Japan 15 331 1.1× 167 0.7× 92 0.8× 54 0.5× 117 1.2× 20 883
Qin Yin China 20 435 1.4× 214 1.0× 151 1.3× 76 0.8× 121 1.2× 56 1.1k
Byung Yong Rhim South Korea 21 421 1.4× 330 1.5× 123 1.1× 104 1.0× 141 1.4× 37 1.2k
Jacqueline M. Lopes de Faria Brazil 21 388 1.3× 168 0.8× 123 1.1× 58 0.6× 146 1.4× 34 1.3k
Hanna Shevalye United States 23 309 1.0× 586 2.6× 103 0.9× 105 1.0× 76 0.8× 40 1.2k
Sonja Zafirović Serbia 17 391 1.3× 158 0.7× 181 1.6× 48 0.5× 156 1.5× 35 1.0k
Ya‐Shuo Zhao China 20 468 1.5× 246 1.1× 118 1.0× 60 0.6× 116 1.1× 39 1.3k
Ana Karolina Santana Nunes Brazil 13 313 1.0× 162 0.7× 193 1.7× 89 0.9× 70 0.7× 17 804

Countries citing papers authored by Chi Dae Kim

Since Specialization
Citations

This map shows the geographic impact of Chi Dae Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Dae Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Dae Kim more than expected).

Fields of papers citing papers by Chi Dae Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Dae Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Dae Kim. The network helps show where Chi Dae Kim may publish in the future.

Co-authorship network of co-authors of Chi Dae Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Dae Kim. A scholar is included among the top collaborators of Chi Dae Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Dae Kim. Chi Dae Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Yuna, Hyori Kim, So Min Lee, et al.. (2024). Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cells. Molecular Therapy. 32(11). 3879–3894. 20 indexed citations
2.
3.
4.
5.
6.
Lee, Seung Jin, et al.. (2016). Osteopontin plays a key role in vascular smooth muscle cell proliferation via EGFR-mediated activation of AP-1 and C/EBPβ pathways. Pharmacological Research. 108. 1–8. 30 indexed citations
7.
Lee, Hye Rin, Hwa Kyoung Shin, So Youn Park, et al.. (2015). Cilostazol Upregulates Autophagy via SIRT1 Activation: Reducing Amyloid-β Peptide and APP-CTFβ Levels in Neuronal Cells. PLoS ONE. 10(8). e0134486–e0134486. 35 indexed citations
8.
Lee, Seung Jin, Kyo Won Seo, & Chi Dae Kim. (2015). LPS Increases 5-LO Expression on Monocytes via an Activation of Akt-Sp1/NF-κB Pathways. Korean Journal of Physiology and Pharmacology. 19(3). 263–263. 23 indexed citations
9.
Park, So Youn, Sung Won Lee, Seung Hoon Baek, et al.. (2011). Induction of heme oxygenase-1 expression by cilostazol contributes to its anti-inflammatory effects in J774 murine macrophages. Immunology Letters. 136(2). 138–145. 16 indexed citations
10.
Park, So Youn, Sung Won Lee, Hwa Kyoung Shin, et al.. (2010). Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2‐linked heme oxygenase 1 induction. Arthritis & Rheumatism. 62(3). 732–741. 56 indexed citations
11.
Park, Ji Young, Hwa Kyoung Shin, Young Whan Choi, et al.. (2009). Gomisin A induces Ca2+-dependent activation of eNOS in human coronary artery endothelial cells. Journal of Ethnopharmacology. 125(2). 291–296. 16 indexed citations
12.
Yun, Mi Ran, et al.. (2009). Cilostazol Attenuates 4-hydroxynonenal-enhanced CD36 Expression on Murine Macrophages via Inhibition of NADPH Oxidase-derived Reactive Oxygen Species Production. Korean Journal of Physiology and Pharmacology. 13(2). 99–99. 12 indexed citations
13.
Park, So Youn, Hwa Kyoung Shin, Jeong Hyun Lee, et al.. (2009). Cilostazol Ameliorates Metabolic Abnormalities with Suppression of Proinflammatory Markers in a db/db Mouse Model of Type 2 Diabetes via Activation of Peroxisome Proliferator-Activated Receptor γ Transcription. Journal of Pharmacology and Experimental Therapeutics. 329(2). 571–579. 36 indexed citations
14.
Park, So Youn, Jeong Hyun Lee, Hwa Kyoung Shin, et al.. (2008). Synergistic Efficacy of Concurrent Treatment with Cilostazol and Probucol on the Suppression of Reactive Oxygen Species and Inflammatory Markers in Cultured Human Coronary Artery Endothelial Cells. Korean Journal of Physiology and Pharmacology. 12(4). 165–165. 12 indexed citations
15.
Lee, Jeong Hyun, So Youn Park, Hwa Kyoung Shin, et al.. (2008). Protective Effects of Cilostazol against Transient Focal Cerebral ischemia and Chronic Cerebral Hypoperfusion Injury. CNS Neuroscience & Therapeutics. 14(2). 143–152. 40 indexed citations
16.
Park, So Youn, Jeong Hyun Lee, Chi Dae Kim, et al.. (2007). Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats. Brain Research. 1157. 112–120. 26 indexed citations
17.
Lee, Jeong Hyun, So Youn Park, Yung Woo Shin, et al.. (2007). Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats. Brain Research. 1185. 246–255. 39 indexed citations
18.
Lee, Ji Young, Hye Jin Heo, Mi Ran Yun, et al.. (2006). 4-Hydroxynonenal induces vascular smooth muscle cell apoptosis through mitochondrial generation of reactive oxygen species. Toxicology Letters. 166(3). 212–221. 70 indexed citations
19.
Lee, Jeong Hyun, So Youn Park, Yung Woo Shin, et al.. (2006). Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion. Brain Research. 1082(1). 182–191. 62 indexed citations
20.
Hong, Ki Whan, et al.. (1997). Decreased CGRP level with increased sensitivity to CGRP in the pial arteries of spontaneously hypertensive rats. Life Sciences. 60(10). 697–705. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hui Fu Breakdown of academic impact, for papers by Masahiro Okouchi Breakdown of academic impact, for papers by Qin Yin Breakdown of academic impact, for papers by Byung Yong Rhim Breakdown of academic impact, for papers by Jacqueline M. Lopes de Faria Breakdown of academic impact, for papers by Hanna Shevalye Breakdown of academic impact, for papers by Sonja Zafirović Breakdown of academic impact, for papers by Ya‐Shuo Zhao Breakdown of academic impact, for papers by Ana Karolina Santana Nunes
Rankless by CCL
2026